MAM
ALXN

Morse Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Morse Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,440
Closed -$1.51M – 141
2017
Q1 		$1.51M Buy
+12,440
New +$1.51M 0.51% 63